Foxp3-#32

N/A

Report date: 2025/01/26 16:37:17

Base Information

Drug NameFoxp3-#32
Drug Alias NameAnti-Foxp3/HLA-A*0201 antibody (Eureka Therapeutics)Treg modulator (Eureka Therapeutics)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionHLA Class I Histocompatibility Antigen, A-2 alpha Chain modulatorsForkhead box protein P3 modulators
TargetsForkhead box protein P3HLA Class I Histocompatibility Antigen, A-2 alpha Chain
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEureka Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesEureka Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A